News & Stories

Research

Papers of the month: September 2026

Check out some of the papers that were recently published by DMCBH members: Jan Lünemann: De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD   Journal: Neurology  New antibody tests and targeted treatments have greatly improved care for conditions such as aquaporin-4 antibody neuromyelitis optica spectrum disorder (AQP4-Ab NMOSD) and MOG-antibody-associated disease (MOGAD), reducing relapses and improving long-term outcomes. However, researchers…

Read More

Join Our Mailing List

Keep updated with DMCBH news with our monthly Brain Matters email newsletter.






In the Media

Name Media Outlet Date Article
Judy Illes The Ubyssey 12/06/2025 Decolonizing neuroscience: Cross-cultural practice and reframing the field
Erik Pioro Global News 28/04/2025 Exploring UBC’s new ALS clinic
Brain MacVicar Global News 11/04/2025 UBC researchers create mini human brains to study Alzheimer’s
Catharine Winstanley The Tyee 10/04/2025 By Attacking Science, Poilievre Takes a Page from Trump’s Playbook

Events

Dr. Yves De Koninck: Chloride dysregulation as a new therapeutic target: from chronic pain to neurodegenerative diseases

October 5

2215 Wesbrook Mall
Vancouver, British Columbia V6T 1Z3 Canada

I will present work we have pursued to identify key mechanisms explaining aberrant pain processing by the nervous system as well as co-morbidities that develop from sustained pain hypersensitivity. This includes the discovery of impaired inhibition resulting from chloride dysregulation in neuropathic pain conditions, leading to crosstalk between sensory channels, a probable substrate of abnormal touch-evoked pain (allodynia), and ectopic…

Read More